| |
| |
|
| Insider
Information: |
Attar Eyal C. |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
170,086 |
|
|
Indirect Shares
|
331 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
170,417 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aprea Therapeutics, Inc. |
APRE |
SVP, Chief Medical Off... |
2022-06-03 |
57,233 |
2022-06-03 |
331 |
Premium* |
|
|
Vor Biopharma Inc. |
VOR |
|
2024-02-06 |
112,853 |
2023-02-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VOR |
Vor Biopharma Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2024-02-06 |
4 |
D |
$2.32 |
$2,738 |
D/D |
(1,180) |
112,853 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
CHIEF MEDICAL OFFICER |
• – – |
2024-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
114,033 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
Chief Medical Officer |
• – – |
2023-11-06 |
4 |
D |
$1.82 |
$1,818 |
D/D |
(999) |
51,533 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
Chief Medical Officer |
• – – |
2023-08-07 |
4 |
D |
$2.67 |
$2,667 |
D/D |
(999) |
52,532 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
Chief Medical Officer |
• – – |
2023-05-08 |
4 |
D |
$4.14 |
$4,012 |
D/D |
(969) |
53,531 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
Chief Medical Officer |
• – – |
2023-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
54,500 |
54,500 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• • – |
2022-06-03 |
4 |
D |
$0.81 |
$26,297 |
D/D |
(32,667) |
57,233 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
42,900 |
89,900 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2022-02-28 |
4 |
AS |
$1.73 |
$62,280 |
D/D |
(36,000) |
47,000 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-09-16 |
4 |
AS |
$4.68 |
$74,730 |
D/D |
(15,968) |
83,000 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-08-25 |
4 |
D |
$3.98 |
$35,947 |
D/D |
(9,032) |
98,968 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
108,000 |
108,000 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
SVP, Chief Medical Officer |
• • – |
2019-10-07 |
4 |
B |
$15.00 |
$6,000 |
I/I |
400 |
200 |
0.01 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
